Holen Sie sich die Stockscreener-App
55.14
2.89%
1.55
Schlusskurs vom Vortag:
$53.59
Offen:
$52.51
24-Stunden-Volumen:
1.62M
Relative Volume:
1.49
Marktkapitalisierung:
$2.80B
Einnahmen:
$534.53M
Nettoeinkommen (Verlust:
$-11.45M
KGV:
-228.70
EPS:
-0.2411
Netto-Cashflow:
$48.28M
1W Leistung:
-5.55%
1M Leistung:
+4.85%
6M Leistung:
+89.68%
1J Leistung:
+60.80%
1-Tages-Spanne:
$52.00
$55.25
1-Wochen-Bereich:
$52.00
$59.05
52-Wochen-Spanne:
$25.36
$61.70
Atricure Inc Stock (ATRC) Company Profile
Firmenname
Atricure Inc
Sektor
Telefon
513-755-4100
Adresse
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, RMD, MDLN, ALC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
55.14 | 2.97B | 534.53M | -11.45M | 48.28M | -0.2411 |
ISRG
Intuitive Surgical Inc
|
391.95 | 143.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
176.80 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
218.89 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.61 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.76 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-18 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2026-02-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-04-23 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2021-08-05 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Bestätigt | Needham | Buy |
| 2020-11-06 | Bestätigt | Needham | Buy |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-24 | Bestätigt | Needham | Buy |
| 2019-08-13 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-04 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Stifel | Buy |
| 2018-06-18 | Bestätigt | Needham | Buy |
| 2018-04-27 | Bestätigt | Needham | Buy |
| 2018-01-16 | Bestätigt | Needham | Buy |
| 2017-11-02 | Bestätigt | Needham | Buy |
| 2017-07-28 | Bestätigt | Needham | Buy |
| 2017-05-30 | Fortgesetzt | Piper Jaffray | Overweight |
| 2016-06-30 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2015-10-28 | Bestätigt | Needham | Buy |
| 2015-10-06 | Bestätigt | Canaccord Genuity | Buy |
| 2015-10-06 | Bestätigt | Needham | Buy |
Alle ansehen
Atricure Inc Aktie (ATRC) Neueste Nachrichten
AtriCure, Inc. (ATRC) Stock Forecasts - Yahoo Finance
AtriCure Inc (ATRC) Shares Fall 3.2% -- GF Value Says Still Over - GuruFocus
ETFs Investing in AtriCure, Inc. Stocks - TradingView
Debt to assets ratio of AtriCure, Inc. – HAN:A5I - TradingView
How (ATRC) Movements Inform Risk Allocation Models - Stock Traders Daily
AtriCure (ATRC) Stock Looks Rich Against Its Sales Base - Yahoo Finance
AtriCure Inc (ATRC) Shares Fall 3.9% -- What GF Score of 77 Tells Investors - GuruFocus
Why AtriCure (ATRC) Is Back In The Spotlight - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $271,140 in stock - Investing.com
Form 4 AtriCure Inc For: 24 September By Investing.com - Investing.com Nigeria
AtriCure CTO Salvatore Privitera sells $271,140 in stock By Investing.com - Investing.com Nigeria
Form 4 AtriCure Inc For: 24 September - Investing.com India
AtriCure (ATRC) Chief Technical Officer Salvatore Privitera Sells 4,519 Shares - GuruFocus
Atricure Insider Sold Shares Worth $271,140, According to a Recent SEC Filing - marketscreener.com
AtriCure (ATRC) officer sells shares at $60 each under a trading plan. - Stock Titan
Biotech Stocks At 52-Week HighsTKNO, MRNA, ATRC, ILMN - RTTNews
AtriCure, Inc. (ATRC) Stock forecasts - Yahoo Finance Singapore
Form 144 ATRICURE For: 23 September - Investing.com India
Form 144 ATRICURE For: 23 September By Investing.com - Investing.com Canada
After two September sales, AtriCure (ATRC) officer Salvatore Privitera proposes another worth $271,140. - Stock Titan
AtriCure stock hits 52-week high at $59.91 - Investing.com
AtriCure stock hits 52-week high at $59.91 By Investing.com - Investing.com South Africa
AtriCure, Inc. (ATRC) Stock Price, News, Quote & History - Yahoo! Finance Canada
AtriCure stock falls 1.45 percent as earnings approach - AD HOC NEWS
AtriCure, Inc.(NasdaqGM: ATRC) added to S&P 1000 - marketscreener.com
AtriCure, Inc.(NasdaqGM: ATRC) added to S&P 600 Health Care - marketscreener.com
AtriCure, Inc.(NasdaqGM: ATRC) added to S&P Composite 1500 - marketscreener.com
AtriCure stock holds firm as recent insider buying follows solid 2026 results - AD HOC NEWS
Atricure Stock Price Forecast. Should You Buy ATRC? - StockInvest.us
AtriCure stock gains as analysts highlight upside and valuation risks - AD HOC NEWS
AtriCure Inc (ATRC) Shares Surge 3.4% -- What GF Score of 75 Tel - GuruFocus
Stifel reiterates Buy rating on AtriCure stock, $65 target By Investing.com - Investing.com South Africa
Stifel reiterates Buy rating on AtriCure stock, $65 target - Investing.com
Stifel Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $65 - Moomoo
AtriCure Director Regina E. Groves Sells 5,313 Shares at $54.22 Each (NASDAQ: ATRC) - Kalkine Media
Insider Selling: Regina E Groves Unloads $288K Of AtriCure Stock - Benzinga
Director Regina Groves Sells 5,313 Shares of AtriCure Inc (ATRC) - GuruFocus
AtriCure director Regina Groves sells $288,070 of stock By Investing.com - Investing.com South Africa
AtriCure director Regina Groves sells $288,070 of stock - Investing.com
AtriCure (NASDAQ: ATRC) director sells shares with no 10b5-1 plan filed - Stock Titan
AtriCure stock hits 52-week high at 55.83 USD By Investing.com - Investing.com Nigeria
AtriCure stock hits 52-week high at 55.83 USD - Investing.com
AtriCure Executive Stock Sale Analysis - Intellectia AI
AtriCure CTO Sells 3,657 Shares - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares By Investing.com - Investing.com Nigeria
Director at AtriCure (NASDAQ: ATRC) plans $285K stock sale - Stock Titan
AtriCure (ATRC) Chief Technical Officer Salvatore Privitera Sells 3,657 Shares - GuruFocus
Do Options Traders Know Something About AtriCure Stock We Don't? - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares - investing.com
Finanzdaten der Atricure Inc-Aktie (ATRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.06%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):